1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Life...

Let's Pass it on...

Know More

Organs wasted are lives lost....

Become an Organ Donor-Saves Lives...

Know More

Don't Take your organs to Heaven...

Know More

Organ Donation

If you save one life,It is as though you save the world

12Dec/11

Toxicity Without Benefit With Paclitaxel Plus Everolimus – Medscape

December 12, 2011Immunosuppressive Drugsadmin

Toxicity Without Benefit With Paclitaxel Plus EverolimusMedscapeDecember 12, 2011 (San Antonio, Texas) — It seemed like a good idea at the time, but including everolimus (Afinitor, Novartis) in a neoadjuvant chemotherapy regimen with paclitaxel (Taxo…

12Dec/11

Fractionated 90 Y-Ibritumomab Tiuxetan Effective as First-Line Therapy for … – Monthly Prescribing Reference

December 12, 2011Monoclonal Anti-CD20 Antibodiesadmin

Fractionated 90 Y-Ibritumomab Tiuxetan Effective as First-Line Therapy for …Monthly Prescribing ReferencePatients with >20% bone marrow (BM) involvement received fractionated RIT only if a repeat BM biopsy demonstrated a reduction to ≤20% involv…

12Dec/11

Wellpoint: Oppenheimer Funds' Largest Healthcare Stock Holding in Q3 – Wall St. Cheat Sheet

December 12, 2011Transplant Rejectionadmin

Wellpoint: Oppenheimer Funds' Largest Healthcare Stock Holding in Q3Wall St. Cheat SheetThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejec…

12Dec/11

Breast cancer victims 'can double survival time' – Trade Arabia

December 12, 2011Immunosuppressive Drugsadmin

Breast cancer victims 'can double survival time'Trade ArabiaWomen suffering from breast cancer can survive for twice as long without disease progression using the Novartis-made drug Afinitor (everolimus) in conjunction with hormonal therapy, sa…

12Dec/11

Excellent PFS and OS Observed with CHOP Combination Regimens in Newly … – Monthly Prescribing Reference

December 12, 2011Monoclonal Anti-CD20 Antibodiesadmin

Excellent PFS and OS Observed with CHOP Combination Regimens in Newly …Monthly Prescribing ReferenceThe CHOP-R arm of patients received six cycles of CHOP chemotherapy (cyclophosphamide 750mg/m 2 , doxorubicin 50mg/m 2 , vincristine 1.4mg/m 2 , and p…

12Dec/11

Celladon Corporation Receives FDA Fast Track Designation for Its … – PR Newswire (press release)

December 12, 2011Organ Failureadmin

Celladon Corporation Receives FDA Fast Track Designation for Its …PR Newswire (press release)"The positive results of the phase 2 CUPID Trial demonstrated the potential of MYDICAR® to become an important treatment for patients with chronic, adv…

12Dec/11

AMAG's anemia drug gets Canadian approval – Reuters Canada

December 12, 2011Organ Failureadmin

AMAG's anemia drug gets Canadian approvalReuters CanadaO: Quote) said Canadian health regulators approved Feraheme, its drug to treat anemia in adults with chronic kidney disease. Health Canada approved two doses of 510 mg of Feraheme, the company&…

12Dec/11

Wake Forest Baptist First Hospital in North Carolina to Implant Newly Approved … – PR Newswire (press release)

December 12, 2011Organ Failureadmin

Wake Forest Baptist First Hospital in North Carolina to Implant Newly Approved …PR Newswire (press release)12, 2011 /PRNewswire-USNewswire/ — A next-generation defibrillator that provides more treatment options and will likely reduce readmissions fo…

12Dec/11

Organ trafficking on the rise in Egypt, says new report – Bikya Masr

December 12, 2011Organ Failureadmin

ZawyaOrgan trafficking on the rise in Egypt, says new reportBikya MasrIllegal organ trafficking in Egypt is on the rise, says a shocking report from the Coalition for Organ Failure Solutions (COFS) Egypt. CAIRO: A shocking new report by the Coalition f…

12Dec/11

Re-treatment strategy challenges maintenance therapy for rituximab use in low … – HemOncToday

December 12, 2011Monoclonal Anti-CD20 Antibodiesadmin

The Oncology ReportRe-treatment strategy challenges maintenance therapy for rituximab use in low …HemOncTodaySAN DIEGO — Patients with low tumor burden follicular lymphoma who received a maintenance dose of rituximab every 3 months did not have a l…

Posts navigation

  • « Previous
  • 1
  • …
  • 18,292
  • 18,293
  • 18,294
  • 18,295
  • 18,296
  • …
  • 18,561
  • Next »

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos